This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Five Prime Therapeutics, Inc., Ucbbiopharma Srl. Active years: 2024.
Company Filing History:
1 out of 77 
1 out of 129 Years Active: 2024
Title: Innovations in Fibrosis Treatment by Timothy Scott Johnson
Introduction
Timothy Scott Johnson is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. His innovative approach has the potential to change the landscape of therapies available for this condition.
Latest Patents
Johnson holds a patent for the "Medical use of interferon-lambda for the treatment of fibrosis." This invention reveals methods for treating fibrosis and demonstrates that interferon-lambda has direct anti-fibrotic effects both in vitro and in vivo. The research indicates that this treatment may provide effective new therapies for various types of fibrosis.
Career Highlights
Throughout his career, Johnson has worked with prominent companies in the biotechnology sector. He has been associated with UCB Biopharma and Five Prime Therapeutics, Inc. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Johnson has collaborated with notable professionals such as Breda Twomey and Janine Powers. These partnerships have enriched his research and expanded the impact of his innovations in the medical field.
Conclusion
Timothy Scott Johnson's work in the treatment of fibrosis through the use of interferon-lambda showcases his dedication to advancing medical science. His patent and collaborations highlight the importance of innovation in developing effective therapies for challenging medical conditions.